Merimepodib, pegylated interferon, and ribavirin in genotype 1 chronic hepatitis C pegylated interferon and ribavirin nonresponders.
Rustgi VK, Lee WM, Lawitz E, Gordon SC, Afdhal N, Poordad F, Bonkovsky HL, Bengtsson L, Chandorkar G, Harding M, McNair L, Aalyson M, Alam J, Kauffman R, Gharakhanian S, McHutchison JG; MErimepodib TRiple cOmbination Study Group.
Rustgi VK, et al. Among authors: gordon sc.
Hepatology. 2009 Dec;50(6):1719-26. doi: 10.1002/hep.23204.
Hepatology. 2009.
PMID: 19852040
Clinical Trial.